Ambu A/S (OTCMKTS:AMBBY – Get Free Report) is one of 660 public companies in the “Holding & other investment offices” industry, but how does it compare to its rivals? We will compare Ambu A/S to similar companies based on the strength of its institutional ownership, valuation, dividends, earnings, analyst recommendations, risk and profitability.
Profitability
This table compares Ambu A/S and its rivals’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Ambu A/S | 7.23% | 6.80% | 5.32% |
Ambu A/S Competitors | -20.14% | -42.65% | -0.81% |
Institutional and Insider Ownership
54.3% of shares of all “Holding & other investment offices” companies are owned by institutional investors. 25.8% of shares of all “Holding & other investment offices” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Earnings & Valuation
Gross Revenue | Net Income | Price/Earnings Ratio | |
Ambu A/S | $684.73 million | $24.09 million | 95.00 |
Ambu A/S Competitors | $1.05 billion | $80.36 million | 48.05 |
Ambu A/S’s rivals have higher revenue and earnings than Ambu A/S. Ambu A/S is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Analyst Ratings
This is a summary of recent ratings and target prices for Ambu A/S and its rivals, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Ambu A/S | 0 | 0 | 1 | 0 | 3.00 |
Ambu A/S Competitors | 126 | 561 | 858 | 15 | 2.49 |
As a group, “Holding & other investment offices” companies have a potential upside of 67.28%. Given Ambu A/S’s rivals higher possible upside, analysts plainly believe Ambu A/S has less favorable growth aspects than its rivals.
About Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.